Olga Šimáková

1.5k citations
24 papers · 1.1k indexed · h-index 16
Topics
Alzheimer's disease research and treatments (6 papers)Mast cells and histamine (5 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)

In The Last Decade

Olga Šimáková

24 papers receiving 1.1k citations

Peers

Olga Šimáková
Comparison fields: 5 of 94
  • Molecular Biology 542
  • Physiology 461
  • Immunology 234
  • Pharmacology 131
  • Cell Biology 120
Replace Surinder M. Soond with:
Surinder M. Soond United Kingdom
Tibor Vántus Hungary
Ronghua Sun China
Martin J. Romeo United States
Yurika Saitoh Japan
Arumugam Muruganandam Canada
Hyangshuk Rhim South Korea
Jenny Presto Sweden
Jonathan Clark United Kingdom
Iris Schvartz Israel
Olga Šimáková relative to Surinder M. Soond United Kingdom Surinder M. Soond's profile →
Citations per field
00.5×5.0×
Surinder M. Soond · 1×
Citations per year

Countries citing papers authored by Olga Šimáková

Since Specialization
Citations

This map shows the geographic impact of Olga Šimáková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Šimáková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Šimáková more than expected).

Fields of papers citing papers by Olga Šimáková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Šimáková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Šimáková. The network helps show where Olga Šimáková may publish in the future.

Co-authorship network of co-authors of Olga Šimáková

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Šimáková. A scholar is included among the top collaborators of Olga Šimáková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Šimáková. Olga Šimáková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 70
2 10
3 52
4 34
5 1
6 15
7 1
8 4
9 48
10 7
11 48
12 24
13 1
14 27
15 154
16 96
17 62
18 3
19 122
20 37

About Olga Šimáková

Olga Šimáková is a scholar working on Genetics, Hematology and Physiology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Mast cells and histamine (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). The work is most often cited by research in Physiology (461 citations), Immunology and Allergy (94 citations) and Immunology (234 citations). Olga Šimáková has collaborated with scholars based in United States, Czechia and India. Frequent co-authors include Nelson Arispe, Juan Carlos Díaz, Harvey B. Pollard, Irina Marić, Jan Šimák, Antonio De Maio, Karel Holada, Silvia H. De Paoli Lacerda, Jana Šemberová and Boris I. Kurganov. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Nano Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026